Edition:
United States

Penumbra Inc (PEN.N)

PEN.N on New York Stock Exchange

157.05USD
25 May 2018
Change (% chg)

$1.05 (+0.67%)
Prev Close
$156.00
Open
$156.15
Day's High
$157.35
Day's Low
$155.75
Volume
28,918
Avg. Vol
59,400
52-wk High
$159.15
52-wk Low
$77.75

Chart for

About

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address... (more)

Overall

Beta: --
Market Cap(Mil.): $5,343.67
Shares Outstanding(Mil.): 34.25
Dividend: --
Yield (%): --

Financials

  PEN.N Industry Sector
P/E (TTM): 211.34 38.82 32.94
EPS (TTM): 0.74 -- --
ROI: 8.16 14.37 12.79
ROE: 7.88 17.21 14.67

BRIEF-Penumbra, Inc. Reports Qtrly Earnings Per Share $0.15

* PENUMBRA, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 08 2018

BRIEF-Penumbra Inc Sees FY 2018 Revenue $400 Mln To $405 Mln

* PENUMBRA, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Feb 27 2018

BRIEF-Penumbra Announces Formation of Joint Venture, MVI Health

* PENUMBRA ANNOUNCES THE FORMATION OF JOINT VENTURE, MVI HEALTH

Jan 04 2018

Competitors

  Price Chg
Terumo Corp (4543.T) ¥6,370 +80.00
Johnson & Johnson (JNJ.N) $121.47 -0.78
Medtronic PLC (MDT.N) $86.30 -0.69
Stryker Corporation (SYK.N) $173.78 -1.26
Boston Scientific Corporation (BSX.N) $30.31 -0.09

Earnings vs. Estimates